About the Authors
- Albina Nowak
-
Contributed equally to this work with: Albina Nowak, Björn Friedrich
* E-mail: albina.nowak@usz.ch
Affiliation Division of Internal Medicine, University Hospital Zürich, Zürich, Switzerland
- Björn Friedrich
-
Contributed equally to this work with: Albina Nowak, Björn Friedrich
Affiliations Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany, Dialysis center Leonberg, Leonberg, Germany
- Ferruh Artunc
-
Affiliation Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany
- Andreas L. Serra
-
Affiliation Division of Nephrology, University Hospital Zürich, Zürich, Switzerland
- Tobias Breidthardt
-
Affiliation Division of Nephrology, University Hospital Basel, Basel, Switzerland
- Raphael Twerenbold
-
Affiliation Division of Cardiology, University Hospital Basel, Basel, Switzerland
- Myriam Peter
-
Affiliation Division of Cardiology, University Hospital Basel, Basel, Switzerland
- Christian Mueller
-
Affiliation Division of Cardiology, University Hospital Basel, Basel, Switzerland
Competing Interests
The authors declare that TECOmedical AG, Switzerland measured the soluble Klotho and FGF23 levels in their hemodialysis cohort for this study. The authors of this manuscript have no commercial or professional association with TECOmedical AG. They have nothing to declare concerning employment, consultancy, patents, products in development, marketed products, etc. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AN BF FA CM. Performed the experiments: BF FA. Analyzed the data: AN AS. Contributed reagents/materials/analysis tools: AN BF FA TB RT MP. Wrote the paper: AN.